Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 49.30
-0.40 (-0.80%)
Jul 30, 2026, 11:24 AM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 5.98 billion as of July 29, 2026. Its market cap has decreased by -26.15% in one year.
Market Cap
5.98B
Enterprise Value
8.11B
Revenue
4.77B
Ranking
n/a
PE Ratio
17.81
Stock Price
49.30
ChartMarket Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 5.98B, an increase of 6.73%. That is a compound annual growth rate of 0.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 5.98B | -16.19% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.71B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 7.05B |
| SCI Pharmtech | 6.18B |
| Orient Pharma | 5.70B |
| Panion & Bf Biotech | 5.12B |
| Easywell Biomedicals | 4.41B |
| LIWANLI Innovation | 4.08B |